Description

Bind Bio AOD 9604

AOD 9604 is a synthetic peptide designed with fragments of human growth hormone (hGH) to mimic its fat-reducing effect. It lacks the diabetogenic effect or the risk of diabetes mellitus[R]. This peptide targets fat cells, promoting fat breakdown (lipolysis). It also inhibits fat storage (lipogenesis) without stimulating muscle growth [R]. .

hGH is a powerful hormone that promotes growth and development in various tissues. This includes fat tissue, which induces insulin resistance in the liver and skeletal muscle [R][R]. Decreased production of hGH, often associated with aging and lifestyle factors, leads to increased fat storage. This may contribute to obesity if left unaddressed [R]. However, when compared to hGH, AOD9604 does not induce hyperglycemia or reduce insulin secretion. It also does not compete for the hGH receptor and does not induce cell proliferation[R]. The lipolytic effects of hGH replacement therapy, particularly on visceral fat, support its role in metabolism. hGH secretion is influenced by the body’s metabolic state. This adaptive mechanism allows the body to maintain metabolic homeostasis.

How does AOD 9604 peptide work?

AOD-9604 mimics the amino acid sequence Tyr-hGH177-191. This is stabilized by an additional tyrosine residue at the N-terminal end. The peptide is cyclized through disulfide bonds [R]. This structural modification allows AOD-9604 to maintain a similar conformation to the native hGH fragment. The C-terminal fragment stimulates fat breakdown (lipolysis) [R].

AOD-9604 shares a similar mechanism of action to how hGH exerts its metabolic effects, including fat metabolism, through insulin-like growth factor-1 (IGF-1) [R]. AOD-9604 exerts its effects by binding to specific preformed hGH receptor dimers on cell surfaces. This triggers a signaling cascade, leading to the recruitment of signal transducer and activator of transcription (STAT) proteins. Once activated, STAT proteins dimerize and translocate to the nucleus. In the nucleus, they bind to specific DNA sequences and regulate gene expression. One key gene regulated is IGF-1, a potent growth factor with various metabolic effects. The interplay between insulin and IGF-1 signaling pathways is crucial for regulating metabolic processes. These processes include lipolysis, proteolysis, and insulin resistance [R].

Properties

AOD-9604

Table source: [R]

Potential Benefits AOD-9604 Peptide Therapy

Anti-obesity: Improved lipolysis leading to weight loss

In a study, the peptide for weight loss, AOD-9604, was tested for its effects in the context of weight loss through a 12-week, double-blind, placebo-controlled trial involving 300 obese participants across five Australian centers. The results showed that both the lowest dose (1 mg) and the highest dose (30 mg) of AOD-9604 led to greater weight loss compared to the placebo group. This suggests that AOD-9604, like human growth hormone (hGH), may act as an effective obesity drug. It could support weight loss, particularly at these specific dose ranges. The findings highlight its potential. However, further research is needed to confirm its long-term safety. Effectiveness remains to be fully established. Continued studies are essential for validation [R][R].

Improve bone health: Prevention of osteoporosis and osteopenia

Ovariectomized rats were treated with two different doses of hexadecapeptide AOD9604 for 12 weeks. Results showed that both doses were effective in preventing bone loss in cortical bone. However, only the lower dose prevented bone loss and improved bone quality in trabecular bone. This suggests that AOD9604 may have therapeutic potential for preventing bone loss. It could improve bone health in postmenopausal women [R].

Improved cartilage health: Promote cartilage regeneration

A group of mature New Zealand white rabbits were randomly administered 2 mg collagenase type II twice in each knee joint with weekly injections of 0.25 mg AOD9604. Combining AOD9604 with hyaluronic acid (HA) showed a synergistic effect in promoting cartilage repair. The treatment also reduced inflammation. The combined treatment reduced the morphological damage seen in osteoarthritic joints. Histopathological damage was also reduced.[R]

AOD9604 Side Effects and Safety Considerations

AOD-9604, a synthetic peptide, has undergone safety assessments in animal studies. These studies in the Journal of endocrinology , have shown that AOD-9604 is generally safe and well-tolerated when administered orally. It was found to have no genotoxic effects and was well-absorbed in the body. While these results are promising, further research is needed to fully understand the long-term safety and efficacy of AOD-9604 in humans [R]. Endogenous hormones are generally safe when used correctly. However, excessive administration of synthetic analogues like AOD-9604 may lead to hormonal imbalances. For instance, overproduction of GHRH can result in an overgrowth of somatotroph cells in the pituitary gland [R].

Why choose Bind Bio to buy AOD-9604?

Bind Bio is your best choice for buying AOD-9604. Why? We carefully chose reliable research chemical suppliers based on strict standards. We focus on ingredients, purity, pricing, and quality to benefit our clients. Our suppliers offer a wide variety of compounds, including peptides, SARMs, sexual wellness compounds, and more. We provide not just one type but all kinds of forms (powder, tablet, etc) to suit your peptide preparation needs. 

Meeting and passing stringent quality control standards is crucial to Bind Bio. We have selected RCD Bio as one of our research chemical suppliers. These top-tier vendors were chosen for their quality and seamless process. We also took into consideration its quality service on fast shipping, receiving payment, and after-sale.

Disclaimer

Bind bio provides general information only. We aim for accuracy and dependability, but we cannot guarantee the information’s completeness, reliability, suitability, or availability. You assume the risk of using such information. The content on Bind bio should not replace nutrition, supplements, medical advice, diagnosis, or treatment. Consult your doctor or other certified health expert with any medical questions. Professional medical advice should never be delayed based on Bind bio information.

Bind bio may include hyperlinks to external websites that are not governed or managed by our organisation. We do not exert control over the nature, content, or availability of those sites. The presence of links and clinical trials does not imply a recommendation or endorsement. Bind Bio is not responsible for any loss or damage, including indirect or consequential losses. This includes data loss or profits resulting from the use of this website. Users are advised to proceed at their own discretion. This disclaimer may be modified or amended at any time without prior notice. By persisting in the use of Bind bio, you acknowledge and consent to adhere to the stipulations outlined in this disclaimer. Should you find these terms unacceptable, we kindly ask that you do not utilize our website.

FAQ

What is the half-life of AOD 9604?

HGH has a relatively short half-life of approximately 21 minutes. As expected, AOD9604, a smaller peptide fragment of hGH, exhibits an even shorter half-life of about 3 minutes following intravenous injection [R]. This rapid clearance is likely due to enzymatic degradation, where AOD9604 is rapidly broken down into smaller amino acids. In terms of oral administration, AOD9604 and its degradation products were still detected in pig plasma. This indicates orally bioavailability of the product. However, the absorption process from the digestive tract is slower compared to intravenous injection.

How Does AOD-9604 Compare to Semaglutide for Fat Loss?

AOD-9604 and semaglutide both target weight management but work differently. AOD-9604 is a fat-burning peptide that mimics natural growth hormone‘s fat metabolism benefits. It focuses directly on fat reduction without affecting appetite. In contrast, semaglutide, an obesity drug, primarily suppresses appetite by mimicking GLP-1, a gut hormone. AOD-9604 is often favored for its safety and tolerability profile. It is especially beneficial for those aiming to improve lipid metabolism. This makes it ideal for achieving targeted fat loss as part of a weight loss journey and exercise.

Is AOD 9604 safe?

AOD9604 has recently received GRAS status. This indicates its safety for use in food, drinks, and dietary supplements [R]. AOD9604 has been tested for safety and efficacy in multiple clinical trials. These intravenous and oral trials showed that AOD9604 is well-tolerated in humans [R]. Early studies suggested that AOD9604 could promote weight loss, particularly targeting abdominal fat.

While AOD9604 appears to be safe, further clinical studies in various subjects, such as obese mice is needed to fully understand its long-term effects and obesity pharmacotherapy

Will AOD-9604 aid fat loss and metabolic health?

As often referred to as a fat burning peptide, it shows promise in supporting a weight loss journey by aiding fat loss and improving lipid metabolism. As one of many peptides explored for chronic weight management. It appears to target body fat by enhancing fat breakdown and reducing fat formation. Studies suggest it may complement exercise and help individuals achieve their weight loss goals without significantly impacting blood sugar levels. This hormone therapy has also shown safety and tolerability in trials. It could be a potential option for fat reduction. Further research is needed to confirm its long-term benefits.